Home/ Stocks/ CODX

Co-Diagnostics, Inc. Common Stock

CODX XNAS

$2.53 +0.62 (+32.15%) ▲ 15-min delayed

Open

$2.16

High

$2.77

Low

$1.90

Volume

10.33M

Market Cap

$9.11M

About Co-Diagnostics, Inc. Common Stock

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 115 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$622.5K	$-46,895,936	$-35.25
FY 2025	$622.5K	$-46,895,936	$-35.25
Q3 2025	$145.4K	$-5,886,823	$-0.16
Q2 2025	$162.9K	$-7,730,117	$-0.23

Related Market News

No specific coverage for CODX yet. Check out our latest market news or earnings calendar.

Get CODX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Co-Diagnostics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.